Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension

ConclusionEHT contributes to the pathogenesis of PAH. The transcription factor Runx1 may be a novel therapeutic target for the treatment of PAH.
Source: Cardiovascular Research - Category: Cardiology Source Type: research